Novartis Investigative Site

Liepāja, LV LV-3414

0 studies enrolling now · 3 studies all time

What they study most

Atherosclerosis, Atherosclerotic Cardiovascular Disease, Heart Failure With Reduced Ejection Fraction

Studies at this site

• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease — Running, not enrolling
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure — Stopped early